KCT0008409
Not yet recruiting
未知
A Randomized Controlled Trial Of Primary Stage I Extra-nodal Marginal Zone Conjunctival Lymphoma: Ultra-low Dose vs. Standard non-inferiority study
ConditionsNeoplasms
Overview
- Phase
- 未知
- Status
- Not yet recruiting
- Enrollment
- 167
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 19(Year) to 80(Year) (—)
- Sex
- All
Inclusion Criteria
- •1\. histologically confirmed primary Ann Arbor stage IE conjunctival MALToma and willing to participate in the study.
- •2\. 19\-80 years of age at the time of diagnosis
- •3\. ECOG performance 0\-2
Exclusion Criteria
- •1\. diagnosed with cancer at another site within 5 years (except for intraepithelial carcinoma of the breast and thyroid)
- •2\. previously received chemotherapy for primary conjunctival MALToma
- •3\. Prior radiation therapy to the ocular region.
- •4\. unable to give informed consent due to mental or physical disability or incapacity.
Investigators
Similar Trials
Recruiting
Phase 1
A Preliminary Randomized Controlled Trial Examining the Effects of Rumination Focused Cognitive Behavioral Therapy on Autism Spectrum Disorder and their Brain BasisAutism Spectrum DisorderJPRN-UMIN000040092Hamamatsu University School of Medicine30
Active, not recruiting
Phase 1
A Preliminary Randomised Controlled Trial using Standard Therapy Vs Mugard - A Preliminary RCT using Standard Therapy Vs Mugard v1Chemotherapy and radiotherapy induced oral mucositisEUCTR2010-019953-16-GBRoyal Devon & Exeter Foundation Trust16
Terminated
Not Applicable
Randomised Control Trial of the Learn to Be Safe with Emmy and FriendsTM Program: Evaluating Changes in Protective Behaviours Knowledge, Intentions and Disclosure of First Grade StudentsEnhancing protective behavioursPublic Health - Health promotion/educationMental Health - Studies of normal psychology, cognitive function and behaviourACTRN12615000917538Griffith University1,620
Active, not recruiting
Phase 1
A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaReCOVID-19 InfectionMedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2020-001449-38-GBChelsea and Westminster Hospital NHS Foundation Trust450
Completed
Not Applicable
Randomized, controlled trial of early intervention with pranlukast for prevention of bronchial asthma in infants with wheezy bronchitis and atopyInfants between 1 and 3 years old, who have severe atopy defined by class 2 and more of Ig E to food and/or environment allergens and history of wheezy bronchitis twice.JPRN-UMIN000000634Japanese Society of Pediatric Allergy and Clinical Immunology200